Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2023

May 15, 2023

BUY
$0.46 - $0.77 $6,118 - $10,241
13,300 New
13,300 $9,000
Q3 2022

Nov 14, 2022

BUY
$1.01 - $17.0 $16,160 - $272,000
16,000 New
16,000 $25,000
Q2 2021

Aug 06, 2021

SELL
$6.81 - $9.23 $102,831 - $139,373
-15,100 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$7.99 - $15.0 $13,583 - $25,500
-1,700 Reduced 10.12%
15,100 $123,000
Q4 2020

Feb 12, 2021

BUY
$7.04 - $11.7 $28,864 - $47,970
4,100 Added 32.28%
16,800 $125,000
Q3 2020

Nov 13, 2020

SELL
$9.98 - $18.04 $28,942 - $52,316
-2,900 Reduced 18.59%
12,700 $137,000
Q2 2020

Aug 13, 2020

BUY
$7.49 - $15.16 $30,709 - $62,156
4,100 Added 35.65%
15,600 $225,000
Q1 2020

May 11, 2020

SELL
$4.62 - $18.74 $28,644 - $116,187
-6,200 Reduced 35.03%
11,500 $100,000
Q4 2019

Feb 12, 2020

SELL
$14.6 - $18.13 $116,800 - $145,040
-8,000 Reduced 31.13%
17,700 $295,000
Q3 2019

Nov 14, 2019

SELL
$16.62 - $23.92 $39,888 - $57,408
-2,400 Reduced 8.54%
25,700 $486,000
Q2 2019

Aug 20, 2019

SELL
$17.79 - $22.88 $103,182 - $132,704
-5,800 Reduced 17.11%
28,100 $643,000
Q1 2019

May 15, 2019

SELL
$11.76 - $22.15 $108,192 - $203,780
-9,200 Reduced 21.35%
33,900 $713,000
Q4 2018

Feb 14, 2019

BUY
$10.42 - $21.94 $228,198 - $480,486
21,900 Added 103.3%
43,100 $508,000
Q3 2018

Nov 14, 2018

BUY
$20.4 - $24.6 $173,400 - $209,100
8,500 Added 66.93%
21,200 $487,000
Q1 2018

May 15, 2018

SELL
$22.55 - $29.9 $239,030 - $316,940
-10,600 Reduced 45.49%
12,700 $290,000
Q4 2017

Feb 14, 2018

SELL
$18.0 - $30.0 $30,600 - $51,000
-1,700 Reduced 6.8%
23,300 $610,000
Q3 2017

Nov 15, 2017

BUY
$21.1 - $25.15 $527,500 - $628,750
25,000
25,000 $561,000

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $168M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.